MediLink Therapeutics Ltd. has hired China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley for a planned ...

Hong Kong is under growing pressure to loosen its rules so that more Chinese companies can shift their listings to the city ...

Hong Kong wants to grasp the opportunities resulting from ongoing trade tensions, the city’s Financial Secretary Paul Chan ...

This strategy works if gold rises in value, allowing Hipine to mark up the prices of its products significantly enough to ...

The final IPO size could reach US$1.48 billion if size adjustment and overallotment options are exercised at the top end of ...

HKEX’s 41 per cent rise this year is set to continue, investment bank says, joining positive calls by Goldman Sachs and HSBC.

China-based biotech Innogen is making a strategic pivot toward international visibility following regulatory clearance of its ...

Hong Kong Financial Secretary Paul Chan says the IPO pipeline is "very strong" and that the "central authorities are very ...

Singapore-based Ant International will apply for the stablecoin issuer’s license in Hong Kong as soon as the city’s ...

The firm joins more than a dozen smart-mobility companies from mainland China aiming to raise funds amid the city’s listing surge.

Shanghai-listed Foshan Haitian Flavouring & Food is the latest Chinese company seeking a secondary listing in Hong Kong.

Dazhong Dental has filed to list in Hong Kong, aiming to attract investors with its status as China's fifth-largest dental services provider by revenue and third-largest by profit The company's ...